dc.creator | Traina, F | |
dc.creator | Carvalheira, JBC | |
dc.creator | Saad, MJA | |
dc.creator | Costa, FF | |
dc.creator | Saad, STO | |
dc.date | 2003 | |
dc.date | 10959 | |
dc.date | 2014-11-17T12:29:23Z | |
dc.date | 2015-11-26T16:27:42Z | |
dc.date | 2014-11-17T12:29:23Z | |
dc.date | 2015-11-26T16:27:42Z | |
dc.date.accessioned | 2018-03-28T23:08:39Z | |
dc.date.available | 2018-03-28T23:08:39Z | |
dc.identifier | Febs Letters. Elsevier Science Bv, v. 535, n. 41699, n. 17, n. 22, 2003. | |
dc.identifier | 0014-5793 | |
dc.identifier | WOS:000180734900005 | |
dc.identifier | 10.1016/S0014-5793(02)03845-0 | |
dc.identifier | http://www.repositorio.unicamp.br/jspui/handle/REPOSIP/55357 | |
dc.identifier | http://www.repositorio.unicamp.br/handle/REPOSIP/55357 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/55357 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1269257 | |
dc.description | In the present study we used K562 cells to demonstrate that insulin receptor substrate 1 (IRS-1) is expressed and constitutively phosphorylated in BCR-ABL(+) cells. We observed association between BCR-ABL/IRS-1, IRS-1/phosphoinositide 3'-kinase (PI3-kinase), and IRS-1/Grb2 in the K562 cell line. Our findings demonstrate that imatinib treatment resulted in marked attenuation of BCR-ABL/IRS-1 association and of IRS-1-stimulated PI3-kinase activity in K562 cells. We concluded that the IRS-1 protein is involved in the signalling pathway of the BCR-ABL tyrosine kinase. (C) 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved. | |
dc.description | 535 | |
dc.description | 41699 | |
dc.description | 17 | |
dc.description | 22 | |
dc.language | en | |
dc.publisher | Elsevier Science Bv | |
dc.publisher | Amsterdam | |
dc.publisher | Holanda | |
dc.relation | Febs Letters | |
dc.relation | FEBS Lett. | |
dc.rights | fechado | |
dc.rights | http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy | |
dc.source | Web of Science | |
dc.subject | imatinib | |
dc.subject | chronic myeloid leukemia | |
dc.subject | BCR-ABL | |
dc.subject | IRS-1 | |
dc.subject | K562 cells | |
dc.subject | Tyrosine Kinase Inhibitor | |
dc.subject | Insulin-receptor Substrate-1 | |
dc.subject | Chronic Myelogenous Leukemia | |
dc.subject | Phosphatidylinositol 3-kinase | |
dc.subject | Signal-transduction | |
dc.subject | Growth-factor | |
dc.subject | Philadelphia-chromosome | |
dc.subject | 3t3-l1 Adipocytes | |
dc.subject | Positive Cells | |
dc.subject | Protein Irs-1 | |
dc.title | BCR-ABL binds to IRS-1 and IRS-1 phosphorylation is inhibited by imatinib in K562 cells | |
dc.type | Artículos de revistas | |